STOCK TITAN
  1. Home
  2. ATBPF

Antibe Therapeut (ATBPF) Stock Price, News & Analysis

ATBPF OTC

Company Description

Antibe Therapeut (OTC: ATBPF) is classified in the medicinal and botanical manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for ATBPF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
52.1M
Shares outstanding

Latest News

View All
0.00%

Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act

+0.19%

Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act

-65.53%

Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance

fda approval
-0.33%

Antibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine Meeting

conferences
+0.49%

Antibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine Meeting

conferences
-46.66%

Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma

Antibe Therapeut has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include fda approval, conferences, earnings. View all ATBPF news →

SEC Filings

View All

No SEC filings available for ATBPF.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ATBPF Company Profile & Sector Positioning

Antibe Therapeut (ATBPF) operates in the Medicinal and Botanical Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.